FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions relates to immunogenic compositions, which contain α-galactosylceramide and a protein antigen of a group B streptococcus. The group of inventions also relates to application of α-galactosylceramide and the protein antigen of the group B streptococcus for induction of the immune response.
EFFECT: application of the claimed group of inventions results in induction of a long-term immunological memory in the absence of repeated doses of the antigen and/or in the absence of multiple priming doses.
27 cl, 19 dwg, 2 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| VACCINE BASED ON B-CELLS, LOADED WITH LIGANDS OF T-CELLS-NATURAL KILLERS AND ANTIGEN | 2006 |
|
RU2420311C2 |
| IMPROVED VACCINATION AGAINST INFLUENZA | 2013 |
|
RU2599496C2 |
| MENINGOCOCCAL CONJUGATE VACCINATION | 2005 |
|
RU2379052C2 |
| VACCINAL COMPOSITION AGAINST HEPATITIS C VIRUS | 2005 |
|
RU2351363C2 |
| VACCINATION WITH MENINGOCOCCAL COJUGATES | 2006 |
|
RU2429011C2 |
| RECOMBINANT TRIVALENT INFLUENZA VACCINE | 2012 |
|
RU2485973C1 |
| IMMUNOGENIC COMPOSITIONS AND METHODS | 2008 |
|
RU2468034C2 |
| EXPRESSION VECTOR BASED ON HUMAN ADENOVIRUS SEROTYPE 5 INDUCING CROSS-PROTECTIVE IMMUNITY TO INFLUENZA A SUBTYPE H3 VIRUSES AND PHARMACEUTICAL COMPOSITION BASED ON IT | 2023 |
|
RU2814189C1 |
| RECOMBINANT ANTI-INFLUENZA VACCINE WITH WIDE RANGE OF PROTECTION AND METHOD FOR ITS PREPARATION | 2017 |
|
RU2757013C2 |
| RECOMBINANT INFLUENZA VIRUS A | 2001 |
|
RU2280690C2 |
